Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSRPH: Acetazolamide, Oxygen, and NIV for Sleep-Disordered Breathing in Pulmonary Hypertension
NCT01427192Phase 2Completed
- Sponsor
- University of Zurich
- Start
- Nov 2010
- Primary completion
- Dec 2012
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acetazolamide in sleep disordered breathing (SDB), sponsored by University of Zurich. Started Nov 2010; status: completed.
02
Drugs
acetazolamide
03
Conditions
sleep disordered breathing (SDB)
Beyond the preview
Go deeper on NCT01427192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01427192.